Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122465) titled 'Construction and effect evaluation of a nurse-led remote symptom management program for Immune-related adverse events in Lung Cancer Patients' on April 14.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Affiliated Cancer Hospital of Guangzhou Medical University
Condition:
Lung cancer
Intervention:
Intervention Group:Nurse-led remote symptom management program for lung cancer immunotherapy-related adverse reactions (including theoretical construction, Delphi expert consultation revision, pilot study, and formal implementation)
Recruitment Status: Recruiting
Phase:...